challenging cases (myeloid neoplasms) – dr. heba raslan (september 15-16, 2023)
Published 7 months ago • 68 plays • Length 29:35Download video MP4
Download video MP3
Similar videos
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
0:52
genomic profiling at diagnosis of myeloid neoplasms
-
1:20
dr. savin on the challenges of developing biosimilar clinical trials
-
1:25
therapeutic targeting of splicing factor mutations in myeloid malignancies
-
0:43
the development of a composite comorbidity index to predict car-t outcomes in patients with dlbcl
-
1:53
phase i trial evaluating a gamma secretase inhibitor in combination with car-t cells in r/r myeloma
-
1:02
challenges with measurable residual disease (mrd) assessment in acute myeloid leukemia (aml)
-
3:25
identifying & monitoring patients with high-risk clonal hematopoiesis
-
0:42
challenges in treating patients with ras-pathway activating mutations in all
-
3:57
challenges in biosimilar acceptance
-
1:18
key recurrent mutations in mds
-
1:44
dr. schmid on challenges concerning biosimilars in oncology
-
1:07
belard trial: belamaf, lenalidomide, and dex in newly diagnosed mm
-
6:09
significantly improving hrql and neurocognition in high-risk sickle cell following familial asct
-
0:53
dr. puhalla on the value of biosimilars in oncology
-
1:32
acute leukemias of ambiguous lineage: biology and treatment approaches
-
1:37
a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
-
3:35
quizartinib advances overall survival in acute myeloid leukaemia patients
-
2:07
the clearance of driver mutations following allosct impacts myelofibrosis disease outcomes